Clinical Trial Update: (Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil? [NA]

View source ↗

Summary

Clinical trial update for the Vertex IIS study investigating whether ivacaftor alters wild-type CFTR-open probability in the sweat gland secretory coil; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (ivacaftor)

Snippet

Sponsor: Richard Barry Moss | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2018-04-20